Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2025-12-26 @ 3:08 AM
Study NCT ID:
NCT07146620
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-04
First Post:
2025-08-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Effectiveness of Radial Nerve Mobilization for Chronic Epicondylalgia
Sponsor:
Universitat Internacional de Catalunya
Organization:
Study Overview
Official Title:
Effectiveness of Radial Nerve Mobilization Techniques and Their Interfaces for Treating Chronic Epicondylalgia
Status:
NOT_YET_RECRUITING
Status Verified Date:
2025-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Effectiveness of radial nerve mobilization techniques and their interfaces for treating chronic epicondylalgia
Intervention: This is a randomized controlled clinical trial that will evaluate the effectiveness of adding radial nerve and its interface mobilization techniques to conventional musculoskeletal treatment.
Participants: Patients over 18 years of age with a diagnosis of chronic epicondylalgia and a positive radial nerve neurodynamic test. Those with previous infiltrations, concomitant pathologies, or contraindications will be excluded.
Study Groups:
* Control Group (n=23): Will receive conventional musculoskeletal treatment.
* Intervention Group (n=23): Will receive the same conventional treatment plus mobilization of the radial nerve and its interfaces.
Primary Outcomes:
* Pain (NPRS).
* Pain and functionality (PRTEE).
* Pressure pain threshold (Algometry).
* Pain-free grip strength (Dynamometry).
* Central sensitization (CSI). Assessments will be conducted at baseline, one week after the last treatment, and 3 months after the last treatment.
Intervention: This is a randomized controlled clinical trial that will evaluate the effectiveness of adding radial nerve and its interface mobilization techniques to conventional musculoskeletal treatment.
Participants: Patients over 18 years of age with a diagnosis of chronic epicondylalgia and a positive radial nerve neurodynamic test. Those with previous infiltrations, concomitant pathologies, or contraindications will be excluded.
Study Groups:
* Control Group (n=23): Will receive conventional musculoskeletal treatment.
* Intervention Group (n=23): Will receive the same conventional treatment plus mobilization of the radial nerve and its interfaces.
Primary Outcomes:
* Pain (NPRS).
* Pain and functionality (PRTEE).
* Pressure pain threshold (Algometry).
* Pain-free grip strength (Dynamometry).
* Central sensitization (CSI). Assessments will be conducted at baseline, one week after the last treatment, and 3 months after the last treatment.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: